The Biden administration will propose expanding Democrats’ new drug pricing law by allowing Medicare to negotiate prices for more drugs, making drugs eligible for negotiation sooner, and expanding penalties for drug price hikes to the commercial market in its budget this year, according to a summary.
The policies, which Biden pitched Tuesday as part of a strategy to shore up the Medicare program’s finances, is in line with progressives’ hopes that once the door was opened to Medicare negotiation, making the program more expansive would be a recurring idea to help save money during congressional debates.